Benzinga | Dec 28, 2021 11:03AM EST

Novavax Whale Trades For December 28

Someone with a lot of money to spend has taken a bearish stance on Novavax (NASDAQ:NVAX).

And retail traders should know.

We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with NVAX, it often means somebody knows something is about to happen.

So how do we know what this whale just did?

Today, Benzinga's options scanner spotted 32 uncommon options trades for Novavax.

This isn't normal.

The overall sentiment of these big-money traders is split between 46% bullish and 53%, bearish.

Out of all of the special options we uncovered, 4 are puts, for a total amount of $331,680, and 28 are calls, for a total amount of $1,300,389.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $65.0 to $350.0 for Novavax over the last 3 months.

Volume & Open Interest Development

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Novavax's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Novavax's whale trades within a strike price range from $65.0 to $350.0 in the last 30 days.

Novavax Option Volume And Open Interest Over Last 30 Days

Biggest Options Spotted:

Symbol PUT/ Trade Sentiment Exp. Strike Total Trade Open Volume CALL Type Date Price Price InterestNVAX PUT TRADE BULLISH 12/31/ $170.00 $210.2K 659 300 21NVAX CALL SWEEP BULLISH 04/14/ $350.00 $179.0K 1.5K 574 22NVAX CALL TRADE BULLISH 01/20/ $140.00 $77.0K 203 121 23NVAX CALL SWEEP NEUTRAL 01/21/ $65.00 $71.4K 300 20 22NVAX CALL TRADE BEARISH 01/07/ $105.00 $66.5K 17 10 22

Where Is Novavax Standing Right Now?

* With a volume of 5,560,455, the price of NVAX is up 6.65% at $168.3.

* RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.

* Next earnings are expected to be released in 62 days.

What The Experts Say On Novavax:

* JP Morgan has decided to maintain their Neutral rating on Novavax, which currently sits at a price target of $209.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you are already an options trader or would like to get started, head on over to Benzinga Pro. Benzinga Pro gives you up-to-date news and analytics to empower your investing and trading strategy.